Document is current
Any future updates will be listed below
-
Authors
Qiu, Jianjian
Yu, Yilin
Wang, Zhiping
Hong, Liang
Shao, Lingdong
Wu, Junxin
-
Funding
Funding for this research was provided by:
the Joint Funds for the National Clinical Key Specialty Construction Program (2021, 2021, 2021, 2021, 2021, 2021)
the Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012, 2020Y2012, 2020Y2012, 2020Y2012, 2020Y2012, 2020Y2012)
Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies (2021Y2014, 2021Y2014, 2021Y2014, 2021Y2014, 2021Y2014, 2021Y2014)
- License Information
-
More Information
Article History
Received: 7 July 2024
Accepted: 13 September 2024
First Online: 27 September 2024
Declarations
:
: The authors declare no competing interests.
: This study was sanctioned by Fujian Cancer Hospital’s Ethics Committee. All patients provided written informed consent.
: The manuscript has been approved by all authors for publication.
